assay
≥99.0% (HPLC)
antibiotic activity spectrum
viruses
mode of action
DNA synthesis | interferes, enzyme | inhibits
SMILES string
Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O
InChI
1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1
InChI key
OIRDTQYFTABQOQ-UHTZMRCNSA-N
General description
Chemical structure: nucleoside
Biochem/physiol Actions
细胞可渗透的腺苷酸环化酶抑制剂；在去污剂分散的大鼠脑制剂中，IC50 = 30 μM。
细胞可渗透的腺苷酸环化酶抑制剂；在去污剂分散的大鼠脑制剂中，IC50 = 30 μM。具有临床意义的抗病毒剂，尤其是通过抑制DNA聚合酶来对抗单纯疱疹病毒（HSV）。
法规信息
新产品
此项目有
Wei Shen et al.
Bioorganic & medicinal chemistry letters, 19(3), 792-796 (2008-12-23)
5'-O-D- and L-amino acid derivatives and 5'-O-(D- and L-amino acid methyl ester phosphoramidate) derivatives of vidarabine (ara-A) were synthesized as vidarabine prodrugs. Some compounds were equi- or more potent in vitro than vidarabine against two pox viruses and their uptake
Larryn W Peterson et al.
Bioorganic & medicinal chemistry letters, 21(13), 4045-4049 (2011-06-07)
We report the synthesis and biological evaluation of Ala-(Val-)l-Ser-CO(2)R prodrugs of 1, where a dipeptide promoiety is conjugated to the P(OH)(2) group of cidofovir (1) via esterification by the Ser side chain hydroxyl group and an ethyl group (4 and
Tadashi Terasaka et al.
Journal of medicinal chemistry, 48(15), 4750-4753 (2005-07-22)
From metabolic considerations and prediction of an inhibitor-induced conformational change, novel adenosine deaminase (ADA) inhibitors with improved activities and oral bioavailability have been developed on the basis of our originally designed non-nucleoside ADA inhibitors. They demonstrated in vivo efficacy in
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 13929-100G | 04061832418643 |